In summary, our study demonstrates that the absence of the IL-33 receptor ST2 is associated with increased tumor invasion, vascular abnormalization, and immunosuppression in murine glioma models where IL-33 is predominantly expressed by oligodendrocytes in the tumor environment. This evidence concerns the gene IL33 and central nervous system cancer.